Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Operating Income of $584.90 million for fiscal year 2025.
WEST PHARMACEUTICAL SERVICES INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $584.90M | +2.6% |
| 2024 | $569.90M | -15.7% |
| 2023 | $676.00M | -7.9% |
| 2022 | $734.00M | -2.4% |
| 2021 | $752.30M | +84.9% |
| 2020 | $406.90M | +37.2% |
| 2019 | $296.60M | +23.4% |
| 2018 | $240.30M | +6.4% |
| 2017 | $225.80M | +15.7% |
| 2016 | $195.20M | +51.8% |
| 2015 | $128.60M | -29.3% |
| 2014 | $182.00M | +12.1% |
| 2013 | $162.40M | +20.2% |
| 2012 | $135.10M | +23.3% |
| 2011 | $109.60M | +20.8% |
| 2010 | $90.70M | -7.0% |
| 2009 | $97.50M | -21.4% |
| 2008 | $124.10M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $167.60M | +3.9% | +9.0% |
| June 30, 2025 | $153.70M | +21.8% | +43.6% |
| March 31, 2025 | $107.00M | -12.9% | -33.7% |
| September 30, 2024 | $161.30M | -9.0% | +27.8% |
| June 30, 2024 | $126.20M | -30.8% | +2.8% |
| March 31, 2024 | $122.80M | -20.9% | -30.7% |
| September 30, 2023 | $177.30M | -4.8% | -2.8% |
| June 30, 2023 | $182.50M | -20.1% | +17.5% |
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +2.6% in Operating Income compared to the prior fiscal year.
- Over the 2008–2025 period, WEST PHARMACEUTICAL SERVICES INC’s operating income has grown by 371.3% (from $124.10 million to $584.90 million).
- The most recent figure is from WEST PHARMACEUTICAL SERVICES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: